The Centers for Medicare & Medicaid Services on May 14th proposed limiting Medicare payments for use of biologic anemia drugs in treating certain cancers and related conditions.
The proposed national coverage decision (NCD) relating to use of anti-anemia biologics– Amgen’s Epogen and Aranesp and Johnson & Johnson’s Procrit — was made in response to a Food […]
-
Tags
- Cancer News
- Cancer Story
- breast-cancer
- breast_cancer
- american_cancer_society
- cervical_cancer
- cancer_patients
- journal_cancer
- prostate_cancer
- metastatic_breast_cancer
- cancer_treatment
- colorectal_cancer
- john_edwards
- cervical_cancer_vaccine
- cancer_drugs
- breast_cancer_patients
- colon_cancer
- cancer_vaccine
- word_cancer
- cancer_vaccines
- cancer_therapies
- cancer_researchers
- cancer_deaths
- elizabeth_edwards
- cancer
- breast_cancer_cases
- cancer-drug
- breast_cancer_research
- BREAST-CANCER-RISK
- cancer_center
-
Archives
